Hepatic decompensation higher with HIV, HCV co-infection

Hepatic decompensation higher with HIV, HCV co-infection

(HealthDay)—Patients co-infected with HIV and hepatitis C virus (HCV) have higher rates of hepatic decompensation than those with HCV monoinfection, according to a study published in the March 18 issue of the Annals of Internal Medicine.

Vincent Lo Re III, M.D., from the University of Pennsylvania and the Philadelphia VA Medical Center, and colleagues conducted a to compare the incidence of hepatic decompensation between 4,280 antiretroviral-treated patients co-infected with HIV and HCV and 6,079 HCV-monoinfected patients. All patients were HCV treatment-naive and had detectable HCV RNA.

The researchers found that, at 10 years, the incidence of hepatic decompensation was 7.4 percent among co-infected patients and 4.8 percent among monoinfected patients (P < 0.001). Co-infected patients had a higher rate of hepatic decompensation than HCV-monoinfected patients (hazard ratio [HR] accounting for competing risks, 1.56). The rate of decompensation was also higher in co-infected patients who maintained HIV RNA levels <1,000 copies/mL compared with HCV-monoinfected patients (HR, 1.44). Among co-infected patients, higher rates of decompensation were associated with baseline advanced hepatic fibrosis (HR, 5.45 with FIB-4 score >3.25); baseline hemoglobin level <100g/L (HR, 2.24); diabetes mellitus (HR, 1.88); and nonblack race (HR, 2.12).

"Despite receiving antiretroviral therapy, patients co-infected with HIV and HCV had higher rates of hepatic decompensation than HCV-monoinfected patients," the authors write.

More information: Full Text (subscription or payment may be required)

Related Stories

Study quantifies prevalence of chronic HCV infection

date Mar 04, 2014

(HealthDay)—The prevalence of hepatitis C virus (HCV) infection is about 1 percent, with 2.7 million U.S. residents estimated as having chronic HCV infection, according to a study published in the March ...

HIV-HCV coinfection speeds HCV-related liver fibrosis

date Feb 27, 2013

(HealthDay)—Individuals who are coinfected with HIV and hepatitis C virus (HCV) exhibit liver fibrosis similar to that of individuals without HIV who are nearly 10 years older, according to research published ...

Better long-term outcomes with low hep C viral load

date Mar 25, 2013

(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, ...

Recommended for you

AAPM: Platelet-rich plasma offers short-term benefit

date 45 minutes ago

(HealthDay)—For patients with facet joint arthropathy, platelet-rich plasma (PRP) has a short-term positive impact, according to a study presented at the annual meeting of the American Academy of Pain Medicine, ...

Brittle bone disease: Drug research offers hope

date 4 hours ago

New research at the University of Michigan offers evidence that a drug being developed to treat osteoporosis may also be useful for treating osteogenesis imperfecta or brittle bone disease, a rare but potentially debilitating ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.